Literature DB >> 8833912

Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice.

F M LaFerla1, C K Hall, L Ngo, G Jay.   

Abstract

The finding that intracellular expression of the beta-amyloid protein (Abeta) under a neuron-specific promoter led progressively to degeneration and death of neurons in the brains of transgenic mice provides a unique opportunity to utilize this animal model to both understand the mechanism that underlies neuronal cell death and define the complexity of events which may ensue. We observed a correlation between Abeta accumulation in selective neurons and activation of p53, a protein that has been implicated in the induction of apoptosis. Histological and immunohistochemical evaluations of adjacent brain sections suggest that expression of p53 is accompanied by nuclear DNA fragmentation. In certain regions with marked neuronal cell death, extracellular deposition of A(beta) became evident, together with the local activation of astrocytes. Interestingly, the neuritic structures underlying the Abeta deposits showed altered synaptophysin immunoreactivity and morphologic evidence for damage. This transgenic mouse model suggests that intracellular generation of the Abeta protein not only leads to the death of the neuron but may also functionally impair neighboring neurons as well. It further offers a mechanism whereby neuritic plaques may be derived.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833912      PMCID: PMC507596          DOI: 10.1172/JCI118957

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease.

Authors:  R Guntern; C Bouras; P R Hof; P G Vallet
Journal:  Experientia       Date:  1992-01-15

2.  Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease.

Authors:  G Perry; P Cras; S L Siedlak; M Tabaton; M Kawai
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

3.  Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.

Authors:  E Masliah; R D Terry; M Alford; R DeTeresa; L A Hansen
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

4.  PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model.

Authors:  M Sasahara; J W Fries; E W Raines; A M Gown; L E Westrum; M P Frosch; D T Bonthron; R Ross; T Collins
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

5.  Intracellular accumulation of beta-amyloid in cells expressing the Swedish mutant amyloid precursor protein.

Authors:  B L Martin; G Schrader-Fischer; J Busciglio; M Duke; P Paganetti; B A Yankner
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

6.  Amyloid beta-peptide is produced by cultured cells during normal metabolism.

Authors:  C Haass; M G Schlossmacher; A Y Hung; C Vigo-Pelfrey; A Mellon; B L Ostaszewski; I Lieberburg; E H Koo; D Schenk; D B Teplow
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

7.  Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

Authors:  M Citron; T Oltersdorf; C Haass; L McConlogue; A Y Hung; P Seubert; C Vigo-Pelfrey; I Lieberburg; D J Selkoe
Journal:  Nature       Date:  1992-12-17       Impact factor: 49.962

8.  Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity.

Authors:  K Fukuchi; K Kamino; S S Deeb; A C Smith; T Dang; G M Martin
Journal:  Biochem Biophys Res Commun       Date:  1992-01-15       Impact factor: 3.575

9.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

Authors:  M Shoji; T E Golde; J Ghiso; T T Cheung; S Estus; L M Shaffer; X D Cai; D M McKay; R Tintner; B Frangione
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  27 in total

Review 1.  p53-dependent cell death signaling in neurons.

Authors:  Richard S Morrison; Yoshito Kinoshita; Mark D Johnson; Weiqun Guo; Gwenn A Garden
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 2.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 3.  Location, location, location: altered transcription factor trafficking in neurodegeneration.

Authors:  Charleen T Chu; Edward D Plowey; Ying Wang; Vivek Patel; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

Review 4.  Pathologies associated with the p53 response.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-07       Impact factor: 10.005

Review 5.  p53 and mitochondrial function in neurons.

Authors:  David B Wang; Chizuru Kinoshita; Yoshito Kinoshita; Richard S Morrison
Journal:  Biochim Biophys Acta       Date:  2014-01-08

6.  Apoptotic actions of p53 require transcriptional activation of PUMA and do not involve a direct mitochondrial/cytoplasmic site of action in postnatal cortical neurons.

Authors:  Takuma Uo; Yoshito Kinoshita; Richard S Morrison
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

7.  A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.

Authors:  Marie P Fogarty; Eric J Downer; Veronica Campbell
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

Review 8.  A common biological mechanism in cancer and Alzheimer's disease?

Authors:  M I Behrens; C Lendon; C M Roe
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

9.  Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates.

Authors:  Tomás R Guilarte; Neal C Burton; Tatyana Verina; Vinaykumar V Prabhu; Kevin G Becker; Tore Syversen; Jay S Schneider
Journal:  J Neurochem       Date:  2008-02-13       Impact factor: 5.372

10.  The p53 homologue p73 accumulates in the nucleus and localizes to neurites and neurofibrillary tangles in Alzheimer disease brain.

Authors:  C Wilson; S Henry; M A Smith; R Bowser
Journal:  Neuropathol Appl Neurobiol       Date:  2004-02       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.